Skip to search formSkip to main contentSkip to account menu

Adriamycin

Known as: Adriamycine, adriablastin, Adriamycin® 
National Institutes of Health

Related topics

Related topics

6 relations
Adria brand of doxorubicinAdriblastinRubex

Broader (2)

DoxorubicinDoxorubicin Hydrochloride

Narrower (1)

Liposomal Adriamycin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1999
Highly Cited
1999
Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system.
The anticancer drug, adriamycin (ADR), was incorporated by physical entrapment into polymeric micelles for selective delivery to… 
Highly Cited
1991
Highly Cited
1991
Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.
Toxicity and in vivo antitumor activity against five solid tumors (C 26, C 38, M 5076, MKN-45, MX-1) of Adriamycin (ADR… 
Highly Cited
1990
Highly Cited
1990
Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.
A novel method for linking Adriamycin (ADM) to monoclonal antibodies is described in which the 13-keto position of the… 
Highly Cited
1989
Highly Cited
1989
Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration.
Highly Cited
1988
Highly Cited
1988
Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay.
Highly Cited
1986
Highly Cited
1986
Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
An adriamycin (ADM)-resistant variant (K562/ADM) of human myelogenous leukemia K562 was established. K562/ADM was stable for 2… 
Highly Cited
1985
Highly Cited
1985
Mechanism of chemical-induced toxicity. I. Use of a rapid centrifugation technique for the separation of viable and nonviable hepatocytes.
Highly Cited
1983
Highly Cited
1983
Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
Resistance to the cytotoxic effects of daunomycin and Adriamycin (ADR) in sublines of Ehrlich ascites and P388 mouse tumors has… 
Highly Cited
1976
Highly Cited
1976
Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts.
Exposure of cultured human lymphoblasts to adriamycin (ADM) (0.1 mug/ml for 24 hr or 0.5 mug/ml for 1 hr) leads to an… 
Highly Cited
1973
Highly Cited
1973
Adriamycin and bleomycin, alone and in combination, in gynecologic cancers
Treatment with adriamycin (ADM) and bleomycin (BLEO) alone and in combination has been evaluated in 56 patients with a variety of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)